TidalSense aims to create a paradigm shift in the practice of respiratory medicine, starting with earlier, accurate diagnosis.
TidalSense has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
TidalSense's investors include Foresight Group, Business Growth Fund, Downing Ventures, SBRI Healthcare.
TidalSense is headquartered in Cambridge, United Kingdom.
TidalSense aims to create a paradigm shift in the practice of respiratory medicine, starting with earlier, accurate diagnosis.
TidalSense is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TidalSense — Funding & Investors." VCBacked, May 16, 2023, https://www.vcbacked.co/company/tidalsense. Accessed July 19, 2026.
VCBacked. (2023). TidalSense — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tidalsense
{{cite web |title=TidalSense — Funding & Investors |url=https://www.vcbacked.co/company/tidalsense |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated